Study Evaluating EKB-569 in Advanced Non-Small Cell Lung Cancer
Clinical trial NCT00067548 · COMPLETED
Trial details
- NCT number
- NCT00067548
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Primary completion
- 2005-01-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.